Company Snapshot

Investment Thesis

Stryker sells implants, surgical tools, robotics, and medical beds that increase procedure volumes and hospital productivity.

  • Mako Robotics: Robotic-assisted joint replacement drives premium pricing.
  • Trauma & Extremities: High-growth portfolio complements core hip/knee business.
  • MedSurg Scale: Beds, stretchers, and Endoscopy equipment create recurring pull-through.

Strategic Mix

MedSurg & Neurotech Endoscopy, instruments, medical beds
Orthopaedics Hips, knees, trauma, extremities
Spine Navigation and interbody devices
Robotics & Digital Mako, planning software, data services

Narrative mix based on public filings, investor days, and Maxim research.

Recent Performance

MTD TBD
QTD TBD
YTD TBD
5Y TBD

Maxim is onboarding this coverage set now. Live market stats and proprietary dashboards will populate after the first nightly data refresh.

Strategic Insights

Procedure Recovery

Aging demographics and backlog support growth.

Robotics Stickiness

Integrated planning software boosts recurring income.

M&A Cadence

Bolt-ons add technologies while leveraging global channel.

Latest Coverage

Curated headlines sourced from Maxim’s AI newsroom.

Loading latest coverage...